Q1 FY27 earnings call transcript filed; revenue up 25% year-on-year
JUBLINGREA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Ingrevia filed Q1 FY27 earnings call transcript. Revenue grew 25% year-on-year to INR 1,300 crore, a 15-quarter high. EBITDA rose 36% to INR 209 crore; PAT up 41% to INR 106 crore. Specialty Chemicals margins hit 26%; Nutrition revenue up 36% with 3-year high segment EBITDA. CDMO pipeline has 100-plus molecules worth over INR 3,500 crore in peak potential, 25 confirmed. Full-year EBITDA guidance of INR 750-800 crore maintained with sequential growth expected.
Strong Q1 results support maintained INR 750-800 crore full-year EBITDA guidance; sequential growth expected but large CDMO contract volumes remain uncertain.